Lung cancer - 9: Molecular biology of lung cancer: clinical implications

被引：87

作者：

Fong, KM

Sekido, Y

Gazdar, AF

Minna, JD

机构：

[1] Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA

[2] Prince Charles Hosp, Brisbane, Qld 4032, Australia

[3] Nagoya Univ, Sch Med, Dept Clin Prevent Med, Showa Ku, Nagoya, Aichi 4668560, Japan

来源：

THORAX | 2003年 / 58卷 / 10期

关键词：

D O I：

10.1136/thorax.58.10.892

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

It has been hypothesised that clinically evident lung cancers have accumulated many different genetic or epigenetic abnormalities in oncogenes and/or tumour suppressor genes. This notion has important clinical ramifications. Recent developments in our knowledge of the molecular biology of lung cancer are reviewed, with particular reference to genetic abnormalities in tumour suppressor gene inactivation and overactivity of growth promoting oncogenes. These changes lead to the "hallmarks of lung cancer''. These hallmarks are the new rational targets for early detection, prevention, and treatment of lung cancer.

引用

收藏

页码：892 / 900

页数：9

相关论文

共 162 条

[51] The hallmarks of cancer [J].

Hanahan, D ;

Weinberg, RA .

CELL, 2000, 100 (01) :57-70

[52] Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer [J].

Hara, H ;

Yamashita, K ;

Shinada, J ;

Yoshimura, H ;

Kameya, T .

LUNG CANCER, 2001, 34 (02) :219-226

[53] PERSONALITY AND THE INHERITANCE OF SMOKING-BEHAVIOR - A GENETIC PERSPECTIVE [J].

HEATH, AC ;

MADDEN, PAF ;

SLUTSKE, WS ;

MARTIN, NG .

BEHAVIOR GENETICS, 1995, 25 (02) :103-117

[54] Tobacco smoke carcinogens and lung cancer [J].

Hecht, SS .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (14) :1194-1210

[55] Early Lung Cancer Action Project: overall design and findings from baseline screening [J].

Henschke, CI ;

McCauley, DI ;

Yankelevitz, DF ;

Naidich, DP ;

McGuinness, G ;

Miettinen, OS ;

Libby, DM ;

Pasmantier, MW ;

Koizumi, J ;

Altorki, NK ;

Smith, JP .

LANCET, 1999, 354 (9173) :99-105

[56] MDM2 gene amplification and expression in non-small-cell lung cancer: Immunohistochemical expression of its protein is a favourable prognostic marker in patients without p53 protein accumulation [J].

Higashiyama, M ;

Doi, O ;

Kodama, K ;

Yokouchi, H ;

Kasugai, T ;

Ishiguro, S ;

Takami, K ;

Nakayama, T ;

Nishisho, I .

BRITISH JOURNAL OF CANCER, 1997, 75 (09) :1302-1308

[57] TELOMERASE ACTIVITY IN SMALL-CELL AND NON-SMALL-CELL LUNG CANCERS [J].

HIYAMA, K ;

HIYAMA, E ;

ISHIOKA, S ;

YAMAKIDO, M ;

INAI, K ;

GAZDAR, AF ;

PIATYSZEK, MA ;

SHAY, JW .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (12) :895-902

[58] Transfection of human insulin-like growth factor-binding protein 3 gene inhibits cell growth and tumorigenicity: a cell culture model for lung cancer [J].

Hochscheid, R ;

Jaques, G ;

Wegmann, B .

JOURNAL OF ENDOCRINOLOGY, 2000, 166 (03) :553-563

[59] Co-expression of epidermal growth factor receptor and transforming growth factor-α is independent of ras mutations in lung adenocarcinoma [J].

Hsieh, ETK ;

Shepherd, FA ;

Tsao, MS .

LUNG CANCER, 2000, 29 (02) :151-157

[60] ALLELE-SPECIFIC CHROMOSOME 3P DELETIONS OCCUR AT AN EARLY-STAGE IN THE PATHOGENESIS OF LUNG-CARCINOMA [J].

HUNG, J ;

KISHIMOTO, Y ;

SUGIO, K ;

VIRMANI, A ;

MCINTIRE, DD ;

MINNA, JD ;

GAZDAR, AF .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (07) :558-563

← 1 2 3 4 5 6 7 8 9 10 →